Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.
Public health officials want more Americans to get the latest COVID vaccine booster. Only 35% of people over 65 have gotten the shot, though 75% of COVID deaths are among people in this age group.
Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
Over-the-counter fever reducers for children are in short supply in some parts of the country. NPR's Daniel Estrin asks pediatrician Christina Johns what advice she gives to parents.
Testing pregnant people's blood to look at free-floating DNA can tell doctors about the health of the fetus. But these tests sometime turn up DNA that might be shed by cancerous cells.
An examination of billing policies and practices at more than 500 hospitals across the country shows widespread reliance on aggressive collection tactics.
A health system charged a woman for a shoulder replacement she didn't need and hadn't received. She didn't receive the care, but she did receive the bill — and some medical records of a stranger.
We mark our days by sunlight, with special receptors in our eyes that respond to light and help reset our body clocks each day. This man can't see, but is still a circadian wiz. Here's how.
Winter can be hard, especially in the halls of healing. A doctor shares how this year's World Cup has become the holiday event she and others didn't know they needed.
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.
Kristen Petranek has a history of miscarriages – and she has diabetes, which makes pregnancy risky. She fears that if something goes wrong, her state's law may inhibit doctors from helping her.
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.
Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu, and COVID spread. But medical experts note that kids' fevers don't always call for medicine.
